Range
137.62 - 141.4
Vol / Avg.
425.2K/439.4K
Div / Yield
-
52 Wk
76.34 - 186.82
Mkt Cap
5B
Payout Ratio
-
Open
139.5
P/E
-
EPS
-1.86
Shares
36.3M
Outstanding
36.3M
Total Float
20M
Benzinga - May 25, 2021, 12:42PM
Benzinga - May 24, 2021, 7:03AM
Benzinga - May 20, 2021, 9:02AM
Benzinga - May 19, 2021, 2:03PM
Benzinga - May 19, 2021, 6:47AM
Benzinga - May 6, 2021, 6:59AM
Benzinga - Apr 26, 2021, 4:55PM
Benzinga - Apr 26, 2021, 2:19PM
Benzinga - Apr 26, 2021, 8:46AM
Benzinga - Mar 1, 2021, 12:54PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-2.100-1.160 0.9400
REV1.190M944.000K-246.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RETAReata Pharmaceuticals-1.31%5B

Reata Pharmaceuticals Frequently Asked Questions

Q

How do I buy Reata Pharmaceuticals (RETA) stock?

A

You can purchase shares of Reata Pharmaceuticals (NASDAQ: RETA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Reata Pharmaceuticals's (RETA) competitors?

A

Other companies in Reata Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Reata Pharmaceuticals (RETA) stock?

A

The latest price target for Reata Pharmaceuticals (NASDAQ: RETA) was reported by Goldman Sachs on May 24, 2021. The analyst firm set a price target for 236.00 expecting RETA to rise to within 12 months (a possible 71.01% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Reata Pharmaceuticals (RETA)?

A

The stock price for Reata Pharmaceuticals (NASDAQ: RETA) is $138 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Reata Pharmaceuticals (RETA) pay a dividend?

A

There are no upcoming dividends for Reata Pharmaceuticals.

Q

When is Reata Pharmaceuticals (NASDAQ:RETA) reporting earnings?

A
Reata Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Reata Pharmaceuticals (RETA) going to split?

A

There is no upcoming split for Reata Pharmaceuticals.

Q

What sector and industry does Reata Pharmaceuticals (RETA) operate in?

A

Reata Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.